Nelson Vergel
Founder, ExcelMale.com
Serum Estradiol, Testosterone, and Sex Hormone-Binding Globulin as Regulators of Peak Bone Mass and Bone Turnover Rate in Young Finnish MenVille-Valtteri Välimäki,
Henrik Alfthan,
Kaisa K. Ivaska,
Eliisa Löyttyniemi,
Kim Pettersson,
Ulf-Håkan Stenman and
Matti J. Välimäki
Division of Endocrinology (V.-V.V., M.J.V.), Department of Medicine, and Department of Clinical Chemistry (H.A., U.-H.S.), Helsinki University Central Hospital, FIN-00290 Helsinki; and Department of Biotechnology (K.K.I., K.P.), and Department of Statistics (E.L.), University of Turku, FIN-20014 Turku, Finland
Address all correspondence and requests for reprints to: Matti Välimäki, M.D., Ph.D., Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, FIN-00290 Helsinki, Finland. E-mail: matti.valimaki{at}hus.fi.
[h=2]Abstract[/b]To study the role of serum testosterone (T), estradiol (E2), and SHBG as regulators of peak bone mass and bone turnover rate in males, a cross-sectional study with data on lifestyle factors collected retrospectively was performed in 204 young Finnish men, 18.3–20.6 yr old. One hundred fifty-four men were recruits of the Finnish Army, and 50 were men of similar age who had postponed their military service for reasons not related to health. Bone mineral content, density, and scan area were measured in lumbar spine and upper femur by dual-energy x-ray absorptiometry. Blood was sampled for determination of serum total and free T, total and free E2, SHBG, type I procollagen aminoterminal propeptide (PINP), total osteocalcin (TOC) and carboxylated osteocalcin (COC), and tartrate-resistant acid phosphatase 5b (TRACP5b); and urine was collected for determination of type I collagen aminoterminal telopeptide (NTX). Serum sex steroid concentrations did not associate with bone mineral content, scan area, or bone mineral density, adjusted for anthropometric and lifestyle factors at any measurement site. Instead, serum total (r = 0.23; P = 0.008) and free (r = 0.15; P = 0.023) T were positive predictors of serum TOC, whereas serum free E2 correlated inversely with serum PINP (r = −0.20; P = 0.0039), TOC (r = −0.12; P = 0.086), COC (r = −0.14; P = 0.036), and urinary NTX (r = −0.15; P = 0.041). Interestingly, serum SHBG correlated positively with all the bone markers studied, the correlation coefficients being 0.18 for serum PINP (P = 0.012), 0.24 for TOC (P = 0.0006), 0.24 for COC (P = 0.0005), 0.27 for serum TRACP5b (P < 0.0001), and 0.21 for urine NTX (P = 0.0031). Serum SHBG was also a positive predictor of serum 25-hydroxyvitamin-D level (r = 0.20; P = 0.0036). The correlations of SHBG persisted after adjusting for weight, free E2, and free T. We conclude that single measurements of serum E2 and T were not determinants of peak bone mass in this population of young men. However, E2 and T contributed to bone turnover rate, with serum T increasing bone formation, and serum E2 suppressing both bone formation and resorption. Moreover, serum SHBG appeared to be an independent positive predictor of bone turnover rate, which also positively associated with serum 25-hydroxyvitamin-D levels.
Henrik Alfthan,
Kaisa K. Ivaska,
Eliisa Löyttyniemi,
Kim Pettersson,
Ulf-Håkan Stenman and
Matti J. Välimäki
Division of Endocrinology (V.-V.V., M.J.V.), Department of Medicine, and Department of Clinical Chemistry (H.A., U.-H.S.), Helsinki University Central Hospital, FIN-00290 Helsinki; and Department of Biotechnology (K.K.I., K.P.), and Department of Statistics (E.L.), University of Turku, FIN-20014 Turku, Finland
Address all correspondence and requests for reprints to: Matti Välimäki, M.D., Ph.D., Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, FIN-00290 Helsinki, Finland. E-mail: matti.valimaki{at}hus.fi.
[h=2]Abstract[/b]To study the role of serum testosterone (T), estradiol (E2), and SHBG as regulators of peak bone mass and bone turnover rate in males, a cross-sectional study with data on lifestyle factors collected retrospectively was performed in 204 young Finnish men, 18.3–20.6 yr old. One hundred fifty-four men were recruits of the Finnish Army, and 50 were men of similar age who had postponed their military service for reasons not related to health. Bone mineral content, density, and scan area were measured in lumbar spine and upper femur by dual-energy x-ray absorptiometry. Blood was sampled for determination of serum total and free T, total and free E2, SHBG, type I procollagen aminoterminal propeptide (PINP), total osteocalcin (TOC) and carboxylated osteocalcin (COC), and tartrate-resistant acid phosphatase 5b (TRACP5b); and urine was collected for determination of type I collagen aminoterminal telopeptide (NTX). Serum sex steroid concentrations did not associate with bone mineral content, scan area, or bone mineral density, adjusted for anthropometric and lifestyle factors at any measurement site. Instead, serum total (r = 0.23; P = 0.008) and free (r = 0.15; P = 0.023) T were positive predictors of serum TOC, whereas serum free E2 correlated inversely with serum PINP (r = −0.20; P = 0.0039), TOC (r = −0.12; P = 0.086), COC (r = −0.14; P = 0.036), and urinary NTX (r = −0.15; P = 0.041). Interestingly, serum SHBG correlated positively with all the bone markers studied, the correlation coefficients being 0.18 for serum PINP (P = 0.012), 0.24 for TOC (P = 0.0006), 0.24 for COC (P = 0.0005), 0.27 for serum TRACP5b (P < 0.0001), and 0.21 for urine NTX (P = 0.0031). Serum SHBG was also a positive predictor of serum 25-hydroxyvitamin-D level (r = 0.20; P = 0.0036). The correlations of SHBG persisted after adjusting for weight, free E2, and free T. We conclude that single measurements of serum E2 and T were not determinants of peak bone mass in this population of young men. However, E2 and T contributed to bone turnover rate, with serum T increasing bone formation, and serum E2 suppressing both bone formation and resorption. Moreover, serum SHBG appeared to be an independent positive predictor of bone turnover rate, which also positively associated with serum 25-hydroxyvitamin-D levels.
